A Type VII Secretion System in Group B Streptococcus Mediates Cytotoxicity And

A Type VII Secretion System in Group B Streptococcus Mediates Cytotoxicity And

bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448449; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 A type VII secretion system in Group B Streptococcus mediates cytotoxicity and 2 virulence 3 4 BL Spencer1, U Tak2†, JC Mendonça 3, PE Nagao 3, M Niederweis2, KS Doran*1 5 6 1University of Colorado Anschutz Medical Campus, Department of Immunology and Microbiology, 7 Aurora, CO, USA 8 2University of Alabama at Birmingham, Department of Microbiology, Birmingham, AL, USA 9 3Rio de Janeiro State University, Roberto Alcântara Gomes Biology Institute, Rio de Janeiro, 10 RJ, Brazil 11 †Present address: University of Colorado Boulder, Department of Biochemistry, Boulder, CO 12 13 * Correspondence: Kelly S. Doran ([email protected]) 14 15 Running title: GBS T7SS mediates virulence 16 17 Keywords: Streptococcus agalactiae, Group B Streptococcus, meningitis, type VII secretion, 18 pore formation, cytotoxicity, EsxA 19 20 21 22 23 24 25 26 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448449; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 27 Abstract 28 Type VII secretion systems (T7SS) have been identified in Actinobacteria and Firmicutes and 29 have been shown to secrete effector proteins with functions in virulence, host toxicity, or 30 interbacterial killing in a few genera. Bioinformatic analysis indicates that Group B streptococcal 31 (GBS) isolates encode four distinct subtypes of T7SS machinery, three of which encode 32 adjacent putative T7SS effectors with WXG and LXG motifs. However, the function of T7SS in 33 GBS pathogenesis is not known. Here we show that the most abundant GBS T7SS subtype is 34 important for virulence and cytotoxicity in brain endothelium and that these phenotypes are 35 dependent on the WXG100 effector EsxA. We further show that the WXG motif is required for 36 cytotoxicity in brain endothelium and that EsxA is a pore-forming protein. This work reveals the 37 importance of a T7SS in host–GBS interactions and has implications for the functions of T7SS 38 effectors in other Gram-positive bacteria. 39 40 Introduction 41 Bacteria utilize secretion systems to respond to changes in environment, defend against 42 interbacterial killing, acquire nutrients, exchange genetic material, and promote virulence within 43 the host 1,2. To date, several secretion systems have been identified in bacteria, but the majority 44 are encoded by Gram-negative organisms. The type VII secretion system (T7SS) was 45 discovered in Mycobacterium tuberculosis (Mtb), in which core machinery components 46 assemble in the inner membrane and utilize an ATPAse to drive secretion of typically small, α- 47 helical proteins lacking traditional signal peptides 3. These proteins are approximately 100 48 amino acids in length and center a tryptophan-variable-glycine (WXG) motif within the hairpin 49 loop between two ɑ-helices; they are designated WXG100 proteins and are now considered 50 canonically secreted factors of T7SSs 4-6. The five ESX systems in Mtb 3 secrete at least 22 51 WXG100 proteins 7 and have been implicated in a number of functions, including phagosomal 52 rupture and macrophage intracellular survival 8,9, toxin secretion 10 and nutrient acquisition 11. 2 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448449; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 53 54 Improvements in next generation sequencing techniques have facilitated the identification of 55 additional T7SS loci in other Actinobacteria (T7SSa) and in Firmicutes (T7SSb) based on 56 homology of ATPase- and WXG100 protein-encoding genes 7. In Firmicutes, the mechanism 57 and components of the T7SSb have been most extensively studied in Staphylococcus aureus 12- 58 16, in which the core machinery consists of four membrane proteins: EsaA, EssA, EssB, and 59 EssC, as well as a cytoplasmic protein, EsaB 17,18. While deletion of any one of these core 60 components can abrogate T7SSb activity 13,19,20, the hexameric, membrane-bound ATPase 61 EssC is considered the driver of T7SSb, of which the ATP-binding domains in the C-terminal 62 region are required for substrate secretion and the C-terminal region is also necessary for 63 substrate recognition and specificity 15,21-23. It has been shown in several Gram-positive bacterial 64 species that the C-terminal sequence of EssC is highly variable across strains, resulting in EssC 65 subtypes that are typically accompanied by a unique set of putative secreted effector-encoding 66 genes 17,24,25. Thus, the effect of the T7SS on a bacterium’s interaction with other normal flora or 67 on fitness within the host may be strain- or EssC subtype-specific. 68 69 Despite large variation in EssC subtypes and their cognate putative effectors between strains 70 and bacterial species, genomic analyses indicate that T7SSb loci encode relatively conserved 71 core components (including the N-terminus of EssC) as well as WXG100 protein EsxA, a widely 72 studied T7SS substrate 12,17,26,27. Increasing numbers of reports have shown a role for the 73 T7SSb and/or EsxA in the pathogenesis of several Gram-positive bacteria 12,28-31; however, 74 T7SSb has not yet been characterized in the important pathogen Streptococcus agalactiae (also 75 known as Group B Streptococcus, GBS). GBS is a β-hemolytic streptococcal species and the 76 leading etiologic agent of bacterial meningitis in neonates 32-34. GBS exists primarily as an 77 asymptomatic colonizer of the gastrointestinal and female reproductive tracts but can cause 78 disease in newborns upon its transmission from the vaginal tract of the mother in utero or during 3 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448449; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 79 birth 35,36. In the newborn, GBS can infect the lungs or blood to cause pneumonia and 80 bacteremia, and in some cases may penetrate the brain resulting in meningitis 37,38. GBS 81 infection among other immunocompromised populations such as elderly adults or adults with 82 cancer or diabetes is also rising in prevalence 39-41. While many factors have been identified that 83 mediate the physical interaction of GBS with the brain endothelial cells that constitute the blood- 84 brain barrier (BBB) 42, the mechanisms by which GBS damages or breaks down that endothelial 85 barrier are still being elucidated. 86 87 Herein, we characterize the T7SSb in GBS. We show by genomic analysis of available whole 88 genome sequences that the GBS T7SS can be divided into at least four subtypes based on the 89 C-terminus of EssC. The GBS T7SS subtype I is the most prevalent, representing >50% of all 90 isolates analyzed. Using a representative subtype I GBS strain, CJB111, we show that deletion 91 of the ATPase-encoding gene, essC, mitigates virulence and GBS-induced inflammation in the 92 brain, as well as cell death in brain endothelial cells and that these phenotypes are dependent 93 on the T7SS canonical substrate EsxA. We further show that the EsxA WXG motif is required 94 for cytotoxicity in brain endothelium and that EsxA is a pore-forming protein. Our study provides 95 the first experimental evidence indicating the T7SS promotes GBS pathogenesis and is the first 96 demonstrate a role for a non-mycobacterial EsxA homolog in pore formation. 97 98 Results 99 Identification of four GBS T7SS subtypes based on EssC protein sequence 100 As a T7SS for major neonatal pathogen GBS has not been described, we analyzed closed 101 genome sequences from GBS isolates for the presence of T7SS core genes and putative 102 effectors. We observed an extensive amount of genetic diversity in T7SS operons in regard to 103 sequence homology of essC, the presence of one or two esxA homologs, as well as the 104 presence of putative T7SS effectors and putative LXG toxin/anti-toxin-encoding genes 4 bioRxiv preprint doi: https://doi.org/10.1101/2021.06.15.448449; this version posted June 15, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 105 downstream of the core T7SS machinery genes. To determine which GBS T7SS subtype might 106 be most prevalent, we examined the C-terminal 225 amino acids of EssC. In S. aureus and 107 Listeria monocytogenes, the EssC C-terminus is the point at which the protein sequence 108 diverges into distinct EssC variants, and each associate with unique downstream putative 109 effector-encoding genes 15,25. Of the 80 GBS whole genome sequenced isolates that encode 110 the 225 C-terminal amino acids of EssC (Table S1), the majority (46/80; 57.5%) encode an 111 EssC variant that we now classify as subtype I (Fig.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    36 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us